S. Dixon-Clarke

发表

Targeted protein degradation as a powerful research tool in basic biology and drug target discovery

E. Fischer, R. Nowak, Tao Wu, 2020, Nature Structural & Molecular Biology.

Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors.

N. Hannett, R. Young, N. Gray, 2016, Nature chemical biology.

Crystal structure of human CUL3 N-terminal domain bound to KEAP1 BTB and 3-box

C. Bountra, C. Arrowsmith, A. Bullock, 2017 .

FOXR2 Is an Epigenetically Regulated Pan-Cancer Oncogene That Activates ETS Transcriptional Circuits

Henry W. Long, James M. McFarland, David C. Jones, 2022, Cancer research.

Structure and inhibitor specificity of the PCTAIRE-family kinase CDK16

T. Sharpe, A. Bullock, K. Sakamoto, 2017, The Biochemical journal.

Targeted protein degradation as a powerful research tool in basic biology and drug target discovery

E. Fischer, R. Nowak, Tao Wu, 2020, Nature Structural & Molecular Biology.

Structures of the CDK12/CycK complex with AMP-PNP reveal a flexible C-terminal kinase extension important for ATP binding

G. Morin, J. Elkins, A. Bullock, 2015, Scientific Reports.

Crystal Structure-Guided Design of Bisubstrate Inhibitors and Photoluminescent Probes for Protein Kinases of the PIM Family

S. Knapp, A. Bullock, A. Chaikuad, 2021, Molecules.